BioCentury
ARTICLE | Clinical News

UT-77: Discontinued Phase II development

July 3, 2000 7:00 AM UTC

United Therapeutics Corp. (UTHR), Silver Spring, Md. Product: UT-77 Business: Pulmonary Therapeutic category: Oxygenation Target: Serine elastase Description: Serine elastase inhibitor Indication: T...